Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
Standard
Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial. / Hagel, Stefan; Bach, Friedhelm; Brenner, Thorsten; Bracht, Hendrik; Brinkmann, Alexander; Annecke, Thorsten; Hohn, Andreas; Weigand, Markus Alexander; Michels, Guido; Kluge, Stefan; Nierhaus, Axel; Jarczak, Dominik; König, Christina; Weismann, Dirk; Frey, Otto; Witzke, Dominic; Müller, Carsten; Bauer, Michael; Kiehntopf, Michael; Neugebauer, Sophie; Lehmann, Thomas; Roberts, Jason A; Pletz, Mathias W; TARGET Trial Investigators.
In: INTENS CARE MED, Vol. 48, No. 5, 05.2022, p. 646-647.Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial
AU - Hagel, Stefan
AU - Bach, Friedhelm
AU - Brenner, Thorsten
AU - Bracht, Hendrik
AU - Brinkmann, Alexander
AU - Annecke, Thorsten
AU - Hohn, Andreas
AU - Weigand, Markus Alexander
AU - Michels, Guido
AU - Kluge, Stefan
AU - Nierhaus, Axel
AU - Jarczak, Dominik
AU - König, Christina
AU - Weismann, Dirk
AU - Frey, Otto
AU - Witzke, Dominic
AU - Müller, Carsten
AU - Bauer, Michael
AU - Kiehntopf, Michael
AU - Neugebauer, Sophie
AU - Lehmann, Thomas
AU - Roberts, Jason A
AU - Pletz, Mathias W
AU - TARGET Trial Investigators
PY - 2022/5
Y1 - 2022/5
U2 - 10.1007/s00134-022-06668-3
DO - 10.1007/s00134-022-06668-3
M3 - Other (editorial matter etc.)
C2 - 35303118
VL - 48
SP - 646
EP - 647
JO - INTENS CARE MED
JF - INTENS CARE MED
SN - 0342-4642
IS - 5
ER -